Tag: INS 2022
INS 2022: Late-breaking research indicates safety of deep brain stimulation in...
Deep brain stimulation (DBS) offers a safe therapy option for reducing chorea in patients with Huntington’s disease, but it remains to be seen whether...
INS 2022: Occipital nerve stimulation shows clinical benefit and safety in...
A randomised controlled trial (RCT) presented at the International Neuromodulation Society (INS) congress (21–26 May 2022, Barcelona, Spain) has demonstrated significant and clinically relevant...
INS 2022: Dorsal horn dendrite stimulation offers “true breakthrough” in pain...
A novel approach to spinal cord stimulation (SCS), which involves targeting the dorsal horn dendrite—in contrast with more traditional ‘axonal’ SCS techniques—has been labelled...
International Neuromodulation Society announces “Innovations in Neuromodulation” event at May congress
With an educational event entitled “Innovations in Neuromodulation”, the International Neuromodulation Society (INS) will attempt to bring together industry leaders, innovators and investors to...
Registration opens for 15th International Neuromodulation Society congress in Barcelona
At the International Neuromodulation Society (INS) 15th world congress (21–26 May 2022; Barcelona, Spain), researchers from over 40 countries will present plenary lectures and...
